Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 14, 2026American Journal of Physical Medicine & Rehabilitation

Clinical Practice Audit of 60-day Temporary Peripheral Nerve Stimulation

View Full Paper
Ask AI
Bookmark
Share

Authors

DSDavid SherwoodOPOishi PaulRHR. Sterling Haring

Discussion

Loading...

Member takes

Overview

Cohort study reveals limited long-term pain relief following sixty-day temporary peripheral nerve stimulation in chronic pain, indicating that sustained post-explant response is uncommon.

Key Points

  • To prospectively evaluate pain relief and functional outcomes up to 14 months following 60-day percutaneous peripheral nerve stimulation in a real-world clinical cohort.
  • Prospective single-center observational cohort study evaluating 102 consecutive patients treated with 60-day temporary percutaneous peripheral nerve stimulation for chronic pain.
  • Tracked clinical outcomes at 2 weeks and at 2, 5, 8, 11, and 14 months, evaluating the primary outcome of ≥50% pain relief alongside functional disability and global impression scores.
  • At 2 weeks and 2 months, ≥50% pain relief occurred in 48.0% (49/102; 95% CI, 38.0–58.2%) and 33.3% (34/102; 95% CI, 24.3–43.4%) of patients, respectively.
  • Pain relief declined progressively after explant, with ≥50% relief reported in 15.7% (16/102; 95% CI, 9.2–24.2%) at 5 months, 9.8% (10/102; 95% CI, 4.8–17.3%) at 8 months, 3.9% (4/102; 95% CI, 1.1–9.7%) at 11 months, and 0.0% (0/102) at 14 months.

Cite This Study

Sherwood et al. (2026) studied this question.

synapsesocial.com/papers/6aa7b42d0926e14a848b3d0bhttps://doi.org/10.1097/phm.0000000000003157
View Full Paper
Ask AI
Bookmark
Share